TrialEuropean heart journal. Cardiovascular pharmacotherapy2024

Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT.

Pascal M Burger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.